202 related articles for article (PubMed ID: 20590165)
1. Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry.
Chen Y; Gruidl M; Remily-Wood E; Liu RZ; Eschrich S; Lloyd M; Nasir A; Bui MM; Huang E; Shibata D; Yeatman T; Koomen JM
J Proteome Res; 2010 Aug; 9(8):4215-27. PubMed ID: 20590165
[TBL] [Abstract][Full Text] [Related]
2. Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins.
Chen Y; Fisher KJ; Lloyd M; Wood ER; Coppola D; Siegel E; Shibata D; Chen YA; Koomen JM
Methods Mol Biol; 2017; 1647():19-45. PubMed ID: 28808993
[TBL] [Abstract][Full Text] [Related]
3. A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer.
Remily-Wood ER; Liu RZ; Xiang Y; Chen Y; Thomas CE; Rajyaguru N; Kaufman LM; Ochoa JE; Hazlehurst L; Pinilla-Ibarz J; Lancet J; Zhang G; Haura E; Shibata D; Yeatman T; Smalley KS; Dalton WS; Huang E; Scott E; Bloom GC; Eschrich SA; Koomen JM
Proteomics Clin Appl; 2011 Aug; 5(7-8):383-96. PubMed ID: 21656910
[TBL] [Abstract][Full Text] [Related]
4. Monitoring a nuclear factor-κB signature of drug resistance in multiple myeloma.
Xiang Y; Remily-Wood ER; Oliveira V; Yarde D; He L; Cheng JQ; Mathews L; Boucher K; Cubitt C; Perez L; Gauthier TJ; Eschrich SA; Shain KH; Dalton WS; Hazlehurst L; Koomen JM
Mol Cell Proteomics; 2011 Nov; 10(11):M110.005520. PubMed ID: 21846842
[TBL] [Abstract][Full Text] [Related]
5. Protein interactions of FAM134B with EB1 and APC/beta-catenin in vitro in colon carcinoma.
Islam F; Chaousis S; Wahab R; Gopalan V; Lam AK
Mol Carcinog; 2018 Nov; 57(11):1480-1491. PubMed ID: 29964340
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
7. Peptide Immunoaffinity Enrichment with Targeted Mass Spectrometry: Application to Quantification of ATM Kinase Phospho-Signaling.
Whiteaker JR; Zhao L; Schoenherr RM; Kennedy JJ; Ivey RG; Paulovich AG
Methods Mol Biol; 2017; 1599():197-213. PubMed ID: 28477121
[TBL] [Abstract][Full Text] [Related]
8. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway.
Amado NG; Predes D; Fonseca BF; Cerqueira DM; Reis AH; Dudenhoeffer AC; Borges HL; Mendes FA; Abreu JG
J Biol Chem; 2014 Dec; 289(51):35456-67. PubMed ID: 25359775
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of direct infusion-multiple reaction monitoring mass spectrometry for quantification of heat shock proteins.
Xiang Y; Koomen JM
Anal Chem; 2012 Feb; 84(4):1981-6. PubMed ID: 22293045
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
[TBL] [Abstract][Full Text] [Related]
11. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines.
Schuierer MM; Graf E; Takemaru K; Dietmaier W; Bosserhoff AK
World J Gastroenterol; 2006 Mar; 12(10):1529-35. PubMed ID: 16570344
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
[TBL] [Abstract][Full Text] [Related]
14. Protocol for the Analysis of Laser Capture Microdissected Fresh-Frozen Tissue Homogenates by Silver-Stained 1D SDS-PAGE.
Prieto DA; Whitely G; Johann DJ; Blonder J
Methods Mol Biol; 2018; 1723():95-110. PubMed ID: 29344855
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
16. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
[TBL] [Abstract][Full Text] [Related]
17. DEAD-box RNA helicase p68 is not required for nuclear translocation of beta-catenin in colon cancer cells.
Stucke VM; Gorses D; Hofmann F
Cell Cycle; 2008 Mar; 7(6):830-2. PubMed ID: 18239468
[No Abstract] [Full Text] [Related]
18. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells.
Flores-Hernández E; Velázquez DM; Castañeda-Patlán MC; Fuentes-García G; Fonseca-Camarillo G; Yamamoto-Furusho JK; Romero-Avila MT; García-Sáinz JA; Robles-Flores M
Cell Signal; 2020 Aug; 72():109636. PubMed ID: 32283254
[TBL] [Abstract][Full Text] [Related]
19. ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells.
Pintova S; Planutis K; Planutiene M; Holcombe RF
Anticancer Res; 2017 Apr; 37(4):1647-1653. PubMed ID: 28373425
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner.
Wang H; Rajan S; Liu G; Chakrabarty S
Cancer Lett; 2008 Jun; 264(2):281-7. PubMed ID: 18367323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]